SUBSCRIBE
MENU
HOME
ABOUT US
Mission and Vision
Management
Board of Directors
Scientific Advisory Board
MYHEART™ PRODUCTS
Overview
Why MyHeart™?
Human Ventricular Cardiomyocytes
Cardiac Anisotropic Sheet
Cardiac Tissue Strip
Cardiac Organoid Chamber
SERVICES
Overview
Screening & Phenotyping Services
Consultation
RESOURCES
Downloads
Online References
Media Kit
INVESTORS
Overview
Stock Information
Press Releases
Financial Information
Corporate Governance
FAQs
Investor Contact
NEWS
Press Releases
Company Updates
Media Coverage
CONTACT
PRESS RELEASES
20
Feb
2020
Novoheart Named 2020 Venture 50 Company Ranked Among Year’s Top Performing Stocks in Life Sciences
21
Jan
2020
Novoheart Contracts with Global Pharma to Develop Novel Microplate for High Throughput Drug Screening Using Engineered Human Heart Tissue Strips
07
Jan
2020
Continued Success of Novoheart to Receive R&D Grants: Innovation Technology Fund for Developing Smart Cardiac Screening Technologies
16
Dec
2019
Novoheart Licenses Harvard Technology to Develop Next-Generation Human Heart-in-a-Jar
30
Nov
2019
Novoheart Announces Change of Fiscal Year-End and Grants Stock Options
<
1
2
3
4
>
Last ›
Subscribe To Our Newsletter
Fill out the following to subscribe and start receiving updates from us!
Subscribe Now
No Thanks
